Sunshine Lake Pharma Co., Ltd. (6887.HK) AI-Powered Stock Analysis
See how Sunshine Lake Pharma Co., Ltd. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
6887.HK●HKSE
HealthcareDrug Manufacturers - Specialty & Generic
HK$28.00
HK$8.70(23.71%)
Hong Kong Market opens in 42h 41m
Sunshine Lake Pharma Co., Ltd. (6887.HK)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerSunshine Lake Pharma Co., Ltd. (6887.HK) Stock Overall Grade
Sunshine Lake Pharma Co., Ltd.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Sunshine Lake Pharma Co., Ltd.'s overall stock rating.
Forecast
BScore
63/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
50/100Key Ratios
C+Score
55/100Sector Comparison
AScore
85/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
C+Score
50/100Sunshine Lake Pharma Co., Ltd. (6887.HK) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 63/100 (B), reflecting high confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (50/100, C+) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (85/100, A) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Sunshine Lake Pharma Co., Ltd. stock grade, including financials, comparisons, and forecasts.